The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease

Frontiers in Physiology

Volumn 3 OCT, Issue , 2012, Pages

  Hartmann, Phillipp ^a   Chen, Wei Chung ^b   Schnabl, Bernd ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

Alcoholic liver disease; Bacterial dysbiosis; Bacterial overgrowth; Bacterial translocation; Microbiome; Steatohepatitis

Indexed keywords

EID: 84870880811     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00402     Document Type: Review

References (145)

1. Adachi, M., and Brenner, D. A. (2005). Clinical syndromes of alcoholic liver disease. Dig. Dis. 23, 255-263.
2. Adachi, Y., Bradford, B. U., Gao, W., Bojes, H. K., and Thurman, R. G. (1994). Inactivation of Kupffer cells prevents early alcohol-induced liver injury. Hepatology 20, 453-460.
3. Adachi, Y., Moore, L. E., Bradford, B. U., Gao, W., and Thurman, R. G. (1995). Antibiotics pre vent liver injury in rats following long-term exposure to ethanol. Gastroenterology 108, 218-224.
4. Akira, S., Uematsu, S., and Takeuchi, O. (2006). Pathogen recognition and innate immunity. Cell 124, 783-801.
5. Aliprantis, A. O., Yang, R. B., Mark, M. R., Suggett, S., Devaux, B., Radolf, J. D., et al. (1999). Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285, 736-739.
6. Al-Sadi, R., Ye, D., Dokladny, K., and Ma, T. Y. (2008). Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability.J. Immunol. 180, 5653-5661.
7. Arvaniti, V., D'Amico, G., Fede, G., Manousou, P., Tsochatzis, E., Pleguezuelo, M., et al. (2010). Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 139, 1246-1256, 1256, el241-1245.
8. Bajaj, J. S., Ridlon, J. M., Hylemon, P. B., Thacker, L. R., Heuman, D. M., Smith, S., et al. (2012). Linkage of gut microbiome with cognition in hepatic encephalopathy. Am. J. Physiol Gastrointest. Liver Physiol. 302, G168-G175.
9. Bajaj, J. S., Zadvornova, Y., Heuman, D. M., Hafeezullah, M., Hoffmann, R. G., Sanyal, A. J., et al. (2009). Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites. Am. J. Gastroenterol. 104, 1130-1134.
10. Basuroy, S., Sheth, P., Mansbach, C. M., and Rao, R. K. (2005). Acetaldehyde disrupts tight junc tions and adherens junctions in human colonic mucosa: protection by EGF and L-glutamine. Am. J. Physiol Gastrointest. Liver Physiol. 289, G367-G375.
11. Bataller, R., and Brenner, D. A. (2005). Liver fibrosis. J. Clin. Invest. 115, 209-218.
12. Bauer, T. M., Schwacha, H., Steinbruckner, B., Brinkmann, F. E., Ditzen, A. K., Kist, M., et al. (2000). Diagnosis of small intestinal bacterial overgrowth in patients with cirrhosis of the liver: poor performance of the glucose breath hydrogen test. J. Hepatol. 33, 382-386.
13. Bauer, T. M., Steinbruckner, B., Brinkmann, F. E., Ditzen, A. K., Schwacha, H., Aponte, J. J., et al. (2001). Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am. J. Gastroenterol. 96, 2962-2967.
14. Berg, R. D., and Garlington, A. W. (1979). Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect. Immun. 23, 403-411.
15. Bjarnason, I., Peters, T. J., and Wise, R. J. (1984). The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet 1, 179-182.
16. Bode, C., and Bode, J. C. (2003). Effect of alcohol consumption on the gut. Best Pract. Res. Clin. Gastroenterol. 17, 575-592.
17. Bode, C., and Bode, J. C. (2005). Activation of the innate immune system and alcoholic liver disease: effects of ethanol per se or enhanced intestinal translocation of bacterial toxins induced by ethanol. Alcohol. Clin. Exp. Res. 29, 166S-171S.
18. Bode, C., Kugler, V., and Bode, J. C. (1987). Endotoxemia in patients with alcoholic and non-alcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J. Hepatol. 4, 8-14.
19. Bode, J. C., Bode, C., Heidelbach, R., Durr, H. K., and Martini, G. A. (1984). Jejunal microflora in patients with chronic alcohol abuse. Hepatogastroenterology 31, 30-34.
20. Bongaerts, G., Severijnen, R., and Timmerman, H. (2005). Effect of antibiotics, prebiotics and pro-biotics in treatment for hepatic encephalopathy. Med. Hypotheses 64, 64-68.
21. Brandl, K., Plitas, G., Mihu, C. N., Ubeda, C., Jia, T., Fleisher, M., et al. (2008). Vancomycin-resistant ente-rococci exploit antibiotic-induced innate immune deficits. Nature 455, 804-807.
22. Camp, J. G., Kanther, M., Semova, I., and Rawls, J. F. (2009). Patterns and scales in gastrointestinal micro-bial ecology. Gastroenterology 136, 1989-2002.
23. Campillo, B., Dupeyron, C., Richardet, J. P., Mangeney, N., and Leluan, G. (1998). Epidemiology of severe hospital-acquired infections in patients with liver cirrhosis: effect of long-term administration of norfloxacin. Clin. Infect. Dis. 26, 1066-1070.
24. Casafont Morencos, F., De Las Heras Castano, G., Martin Ramos, L., Lopez Arias, M. J., Ledesma, F., and Pons Romero, F. (1996). Small bowel bacterial overgrowth in patients with alcoholic cirrhosis. Dig. Dis. Sci. 41, 552-556.
25. Chang, C. S., Chen, G. H., Lien, H. C., and Yeh, H. Z. (1998). Small intestine dysmotility and bacterial overgrowth in cirrhotic patients with spontaneous bacterial peritonitis. Hepatology28, 1187-1190.
26. Chen, Y., Yang, F., Lu, H., Wang, B., Lei, D., Wang, Y., et al. (2011). Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54, 562-572.
27. Christou, L., Pappas, G., and Falagas, M. E. (2007). Bacterial infection-related morbidity and mortality in cirrhosis. Am. J. Gastroenterol. 102, 1510-1517.
28. Clayburgh, D. R., Musch, M. W., Leitges, M., Fu, Y X., and Turner, J. R. (2006). Coordinated epithelial NHE3 inhibition and barrier dysfunction are required for TNF-mediated diarrhea in vivo. J. Clin. Invest. 116, 2682-2694.
29. Craig, R. M., and Atkinson, A. J. Jr. (1988). D-xylose testing: a review. Gastroenterology 95, 223-231.
30. Craig, R. M., and Ehrenpreis, E. D. (1999). D-xylose testing. J. Clin. Gastroenterol. 29, 143-150.
31. D'Amico, G., Garcia-Tsao, G., and Pagliaro, L. (2006). Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J. Hepatol. 44, 217-231.
32. Donald, I. P., Kitchingmam, G., Donald, F., and Kupfer, R. M. (1992). The diagnosis of small bowel bacterial overgrowth in elderly patients. J. Am. Geriatr. Soc. 40, 692-696.
33. Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., et al. (2005). Diversity of the human intestinal microbial flora. Science 308, 1635-1638.
34. Enomoto, N., Ikejima, K., Yamashina, S., Hirose, M., Shimizu, H., Kitamura, T., et al. (2001). Kupffer cell sensitization by alcohol involves increased permeability to gut-derived endotoxin. Alcohol Clin. Exp. Res. 25, 51S-54S.
35. Enomoto, N., Yamashina, S., Kono, H., Schemmer, P., Rivera, C. A., Enomoto, A., et al. (1999). Development of a new, simple rat model of early alcohol-induced liver injury based on sensitization of Kupffer cells. Hepatology 29, 1680-1689.
36. Fadl, A. A., Sha, J., Klimpel, G. R., Olano, J. P., Niesel, D. W., and Chopra, A. K. (2005). Murein lipoprotein is a critical outer membrane component involved in Salmonella enterica serovar typhimurium systemic infection. Infect. Immun. 73, 1081-1096.
37. Fernandez, J., Navasa, M., Gomez, J., Colmenero, J., Vila, J., Arroyo, V., et al. (2002). Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 35, 140-148.
38. Ferrier, L., Berard, F., Debrauwer, L., Chabo, C., Langella, P., Bueno, L., et al. (2006). Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents. Am. J. Pathol. 168, 1148-1154.
39. Fleming, S., Toratani, S., Shea-Donohue, T., Kashiwabara, Y., Vogel, S. N., and Metcalf, E. S. (2001). Pro- and anti-inflammatory gene expression in the murine small intestine and liver after chronic exposure to alcohol. Alcohol Clin. Exp. Res. 25, 579-589.
40. Forsyth, C. B., Farhadi, A., Jakate, S. M., Tang, Y., Shaikh, M., and Keshavarzian, A. (2009). Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol 43, 163-172.
41. Fouts, D. E., Torralba, M., Nelson, K., Brenner, D. A., and Schnabl, B. (2012). Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease. J. Hepatol. 56, 1283-1292.
42. Frank, D. N., St Am and, A. L., Feldman, R. A., Boedeker, E. C., Harpaz, N., and Pace, N. R. (2007). Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc. Natl Acad. Sci. U.S.A. 104, 13780-13785.
43. French, S. W. (2001). Intragastric ethanol infusion model for cellular and molecular studies of alcoholic liver disease. J. Biomed. Sci. 8, 20-27.
44. Fukui, H., Brauner, B., Bode, J. C., and Bode, C. (1991). Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: reevaluation with an improved chromogenic assay. J. Hepatol. 12, 162-169.
45. Gabele, E., Muhlbauer, M., Dorn, C., Weiss, T. S., Froh, M., Schnabl, B., et al. (2008). Role of TLR9 in hepatic stellate cells and experimental liver fibrosis. Biochem. Biophys. Res. Commun. 376, 271-276.
46. Gao, B., and Bataller, R. (2011). Alcoholic liver disease: pathogen-esis and new therapeutic targets. Gastroenterology 141, 1572-1585.
47. Garcia-Tsao, G., Lee, F. Y., Barden, G. E., Cartun, R., and West, A. B. (1995). Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology 108, 1835-1841.
48. Gibson, G. R. (2008). Prebiotics as gut microflora management tools. J. Clin. Gastroenterol. 42(Suppl. 2), S75-S79.
49. Gill, S. R., Pop, M., Deboy, R. T., Eckburg, P. B., Turnbaugh, P. J., Samuel, B. S., et al. (2006). Metagenomic analysis of the human distal gut microbiome. Science 312, 1355-1359.
50. Gines, P., Rimola, A., Planas, R., Vargas, V., Marco, F., Almela, M., et al. (1990). Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology 12, 716-724.
51. Gratz, S. W., Mykkanen, H., and El-Nezami, H. S. (2010). Probiotics and gut health: a special focus on liver diseases. World J. Gastroenterol. 16, 403-410.
52. Guarner, C., Gonzalez-Navajas, J. M., Sanchez, E., Soriando, G., Frances, R., Chiva, M., et al. (2006). The detection of bacterial DNA in blood of rats with CCl4-induced cirrhosis with ascites represents episodes of bacterial translocation. Hepatology 44, 633-639.
53. Guarner, C., Runyon, B. A., Young, S., Heck, M., and Sheikh, M. Y. (1997). Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J. Hepatol. 26, 1372-1378.
54. Guarner, F., and Malagelada, J. R. (2003). Gut flora in health and disease. Lancet 361, 512-519.
55. Gunnarsdottir, S. A., Sadik, R., Shev, S., Simren, M., Sjovall, H., Stotzer, P. O., et al. (2003). Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension. Am. J. Gastroenterol. 98, 1362-1370.
56. Guo, J., Loke, J., Zheng, F., Hong, F., Yea, S., Fukata, M., et al. (2009). Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of Toll-like receptor 4 to hepatic stellate cell responses. Hepatology 49, 960-968.
57. Gupta, A., Dhiman, R. K., Kumari, S., Rana, S., Agarwal, R., Duseja, A., et al. (2010). Role of small intestinal bacterial overgrowth and delayed gastrointestinal transit time in cirrhotic patients with minimal hepatic encephalopathy. J. Hepatol. 53, 849-855.
58. Hritz, I., Mandrekar, P., Velayudham, A., Catalano, D., Dolganiuc, A., Kodys, K., et al. (2008). The critical role of toll-like receptor (TLR) 4 in alcoholic liver disease is independent of the common TLR adapter MyD88. Hepatology 48, 1224-1231.
59. Huang, H., Shiffman, M. L., Friedman, S., Venkatesh, R., Bzowej, N., Abar, 0. T., et al. (2007). A 7 gene sig nature identifies the risk of devel oping cirrhosis in patients with chronic hepatitis C. Hepatology 46, 297-306.
60. Imajo, K., Fujita, K., Nozaki, Y., Shinohara, Y., Suzuki, K., Mawatari, H., et al. (2011). Overexpression of CD 14 in simple steatosis triggers the progression of nonalcoholic steatohepatitis induced by increased sensitivity to low-dose lipopolysaccharide. Hepatology 54, 1166A.
61. Inagaki, T., Moschetta, A., Lee, Y K., Peng, L., Zhao, G., Downes, M., et al. (2006). Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor. Proc. Natl. Acad. Sci. U.S.A. 103, 3920-3925.
62. Inokuchi, S., Tsukamoto, H., Park, E., Liu, Z. X., Brenner, D. A., and Seki, E. (2011). Toll-like receptor 4 mediates alcohol-induced steatohepatitis through bone marrow-derived and endogenous liver cells in mice. Alcohol. Clin. Exp. Res. 35, 1509-1518.
63. Isayama, F., Hines, I. N., Kremer, M., Milton, R. J., Byrd, C. L., Perry, A. W., et al. (2006). LPS signaling enhances hepatic fibro-genesis caused by experimental cholestasis in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G1318-G1328.
64. Jun, D. W., Kim, K. T., Lee, O. Y., Chae, J. D., Son, B. K., Kim, S. H., et al. (2010). Association between small intestinal bacterial overgrowth and peripheral bacterial DNA in cirrhotic patients. Dig. Dis. Sci. 55, 1465-1471.
65. Kamper-Jorgensen, M., Gronbaek, M., Tolstrup, J., and Becker, U. (2004). Alcohol and cirrhosis: dose-response or threshold effect. J. Hepatol. 41, 25-30.
66. Karaa, A., Thompson, K. J., McKillop, 1. H., Clemens, M. G., and Schrum, L. W. (2008). S-adenosyl-L-methionine attenuates oxidative stress and hepatic stellate cell activation in an ethanol-LPS-induced fibrotic rat model. Shock 30, 197-205.
67. Kerlin, P., and Wong, L. (1988). Breath hydrogen testing in bacterial overgrowth of the small intestine. Gastroenterology 95, 982-988.
68. Keshavarzian, A., Choudhary, S., Holmes, E. W., Yong, S., Banan, A., Jakate, S., et al. (2001). Preventing gut leakiness by oats supplementation ameliorates alcohol-induced liver damage in rats. J. Pharmacol. Exp. Ther. 299, 442-448.
69. Kirpich, I. A., Solovieva, N. V., Leikhter, S. N., Shidakova, N. A., Lebedeva, O. V., Sidorov, P. I., et al. (2008). Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study. Alcohol 42, 675-682.
70. Koop, D. R., Klopfenstein, B., Iimuro, Y., and Thurman, R. G. (1997). Gadolinium chloride blocks alcohol-dependent liver toxicity in rats treated chronically with intra-gastric alcohol despite the induction of CYP2E1. Mol. Pharmacol. 51, 944-950.
71. Kudo, H., Takahara, T., Yata, Y., Kawai, K., Zhang, W., and Sugiyama, T. (2009). Lipopolysaccharide triggered TNF-alpha-induced hep-atocyte apoptosis in a murine nonalcoholic steatohepatitis model. J. Hepatol. 51, 168-175.
72. Lata, J., Novotny, I., Pribramska, V., Jurankova, J., Fric, P., Kroupa, R., et al. (2007). The effect of probiotics on gut flora, level of endotoxin and Child-Pugh score in cirrhotic patients: results of a double-blind randomized study. Eur. J. Gastroenterol. Hepatol. 19, 1111-1113.
73. Leber, B., Spindelboeck, W., and Stadlbauer, V. (2012). Infectious complications of acute and chronic liver disease. Semin. Respir. Crit. Care Med. 33, 80-95.
74. Levitt, M. D. (1969). Production and excretion of hydrogen gas in man. N. Engl. I Med. 281, 122-127.
75. Ley, R. E., Backhed, F., Turnbaugh, P., Lozupone, C. A., Knight, R. D., and Gordon, J. I. (2005). Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. U.S.A. 102, 11070-11075.
76. Ley, R. E., Turnbaugh, P. J., Klein, S., and Gordon, J. I. (2006). Microbial ecology: human gut microbes associated with obesity. Nature 444, 1022-1023.
77. Lichtman, S. N., Sartor, R. B., Keku, J., and Schwab, J. H. (1990). Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth. Gastroenterology 98, 414-423.
78. Lieber, C. S., Jones, D. P., and Decarli, L. M. (1965). Effects of prolonged ethanol intake: production of fatty liver despite adequate diets. J. Clin. Invest. 44, 1009-1021.
79. Lin, R. S., Lee, F. Y., Lee, S. D., Tsai, Y T., Lin, H. C., Lu, R. H., et al. (1995). Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation.J. Hepatol. 22, 165-172.
80. Liu, Q., Duan, Z. P., Ha, D. K., Bengmark, S., Kurtovic, J., and Riordan, S. M. (2004). Synbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 39, 1441-1449.
81. Loguercio, C., Federico, A., Tuccillo, C., Terracciano, F., D'Auria, M. V., De Simone, C., et al. (2005). Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J. Clin. Gastroenterol. 39, 540-543.
82. Lorenzo-Zuniga, V., Bartoli, R., Planas, R., Hofmann, A. F., Vinado, B., Hagey, L. R., et al. (2003). Oral bile acids reduce bacterial overgrowth, bacterial translocation, and endotoxemia in cirrhotic rats. Hepatology 37, 551-557.
83. Madrid, A. M., Cumsille, F., and Defilippi, C. (1997). Altered small bowel motility in patients with liver cirrhosis depends on severity of liver disease. Dig. Dis. Sci. 42, 738-742.
84. Madrid, A. M., Hurtado, C., Venegas, M., Cumsille, F., and Defilippi, C. (2001). Long-term treatment with cisapride and antibiotics in liver cirrhosis: effect on small intestinal motility, bacterial overgrowth, and liver function. Am. J. Gastroenterol. 96, 1251-1255.
85. Mandayam, S., Jamal, M. M., and Morgan, T. R. (2004). Epidemiology of alcoholic liver disease. Semin. Liver Dis. 24, 217-232.
86. Marotta, F., Barreto, R., Wu, C. C., Naito, Y., Gelosa, F., Lorenzetti, A., et al. (2005). Experimental acute alcohol pancreatitis-related liver damage and endotoxemia: syn-biotics but not metronidazole have a protective effect. Chin. J. Dig. Dis. 6, 193-197.
87. Mathurin, P., Deng, Q. G., Keshavarzian, A., Choudhary, S., Holmes, E. W., and Tsukamoto, H. (2000). Exacerbation of alcoholic liver injury by enteral endotoxin in rats. Hepatology 32, 1008-1017.
88. McLoughlin, R. M., and Mills, K. H. (2011). Influence of gastrointestinal commensal bacteria on the immune responses that mediate allergy and asthma. J. Allergy Clin. Immunol. 127, 1097-1107. quiz: 1108-1099.
89. Metz, G., Gassull, M. A., Drasar, B. S., Jenkins, D. J., and Blendis, L. M. (1976). Breath-hydrogen test for small-intestinal bacterial colonisation. Lancet 1, 668-669.
90. Miele, L., Valenza, V., La Torre, G., Montalto, M., Cammarota, G., Ricci, R., et al. (2009). Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 49, 1877-1887.
91. Mutlu, E. A., Gillevet, P. M., Rangwala, H., Sikaroodi, M., Naqvi, A., Engen, P. A., et al. (2012). Colonic micro-biome is altered in alcoholism. Am. J. Physiol. Gastrointest. Liver Physiol. 302, G966-G978.
92. Mutlu, E., Keshavarzian, A., Engen, P., Forsyth, C. B., Sikaroodi, M., and Gillevet, P. (2009). Intestinal dysbiosis: a possible mechanism of alcohol-induced endotoxemia and alcoholic steatohepatitis in rats. Alcohol. Clin. Exp. Res. 33, 1836-1846.
93. Nagaki, M., Sugiyama, A., Osawa, Y., Naiki, T., Nakashima, S., Nozawa, Y., et al. (1999). Lethal hepatic apop-tosis mediated by tumor necrosis factor receptor, unlike Fas-mediated apoptosis, requires hepatocyte sen-sitization in mice. J. Hepatol. 31, 997-1005.
94. Nanji, A. A., Khettry, U., and Sadrzadeh, S. M. (1994). Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease). Proc. Soc. Exp. Biol. Med. 205, 243-247.
95. Nanji, A. A., Khettry, U., Sadrzadeh, S. M., and Yamanaka, T. (1993). Severity of liver injury in experimental alcoholic liver disease. Correlation with plasma endotoxin, prostaglandin E2, leukotriene B4, and thromboxane B2. Am. J. Pathol. 142, 367-373.
96. Nischalke, H. D., Berger, C., Aldenhoff, K., Thyssen, L., Gentemann, M., Grunhage, F., et al. (2011). Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis. J. Hepatol. 55, 1010-1016.
97. Novella, M., Sola, R., Soriano, G., Andreu, M., Gana, J., Ortiz, J., et al. (1997). Continuous versus inpa-tient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. Hepatology 25, 532-536.
98. O'Keefe, S. J. (2008). Nutrition and colonic health: the critical role of the microbiota. Curr. Opin. Gastroenterol. 24, 51-58.
99. Pande, C., Kumar, A., and Sarin, S. K. (2009). Small-intestinal bacterial overgrowth in cirrhosis is related to the severity of liver disease. Aliment. Pharmacol. Ther. 29, 1273-1281.
100. Papp, M., Norman, G. L., Vitalis, Z., Tornai, I., Altorjay, I., Foldi, I., et al. (2010). Presence of anti-microbial antibodies in liver cirrhosis-a tell-tale sign of compromised immunity? PloS ONE 5:e12957. doi: 10.1371/journal.pone.0012957
101. Parks, R. W., Clements, W. D., Pope, C., Halliday, M. I., Rowlands, B. J., and Diamond, T. (1996). Bacterial translocation and gut microflora in obstructive jaundice. J. Anat. 189(Pt 3), 561-565.
102. Parlesak, A., Schafer, C., Schutz, T., Bode, J. C., and Bode, C. (2000). Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J. Hepatol. 32, 742-747.
103. Paula, H., Asrani, S. K., Boetticher, N. C., Pedersen, R., Shah, V. H., and Kim, W. R. (2010). Alcoholic liver disease-related mortality in the United States: 1980-2003. Am. J. Gastroenterol. 105, 1782-1787.
104. Petrasek, J., Dolganiuc, A., Csak, T., Nath, B., Hritz, I., Kodys, K., et al. (2011). Interferon regulatory factor 3 and type I interferons are protective in alcoholic liver injury in mice by way of crosstalk of parenchymal and myeloid cells. Hepatology 53, 649-660.
105. Purohit, V., Bode, J. C., Bode, C., Brenner, D. A., Choudhry, M. A., Hamilton, F., et al. (2008). Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol 42, 349-361.
106. Quiroz, S. C., Bucio, L., Souza, V., Hernandez, E., Gonzalez, E., Gomez-Quiroz, L., et al. (2001). Effect of endotoxin pretreatment on hepatic stellate cell response to ethanol and acetaldehyde. J. Gastroenterol. Hepatol. 16, 1267-1273.
107. Raedsch, R., Stiehl, A., Gundert-Remy, U., Walker, S., Sieg, A., Czygan, P., et al. (1983). Hepatic secretion of bilirubin and biliary lipids in patients with alcoholic cirrhosis of the liver. Digestion 26, 80-88.
108. Rao, R. K. (1998). Acetaldehyde-induced increase in paracellular permeability in Caco-2 cell mono-layer. Alcohol. Clin. Exp. Res. 22, 1724-1730.
109. Rao, R. K., Seth, A., and Sheth, P. (2004). Recent advances in alcoholic liver disease, I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. Am. J. Physiol. Gastrointest. Liver Physiol. 286, G881-G884.
110. Rhodes, J. M., Middleton, P., and Jewell, D. P. (1979). The lactulose hydrogen breath test as a diagnostic test for small-bowel bacterial overgrowth. Scand. J. Gastroenterol. 14, 333-336.
111. Riordan, S. M., McIver, C. J., Thomas, D. H., Duncombe, V. M., Bolin, T. D., and Thomas, M. C. (1997). Luminal bacteria and small-intestinal permeability. Scand. J. Gastroenterol. 32, 556-563.
112. Riordan, S. M., Skinner, N. A., McIver, C. J., Liu, Q., Bengmark, S., Bihari, D., et al. (2007). Synbiotic-associated improvement in liver function in cirrhotic patients: relation to changes in circulating cytokine messenger RNA and protein levels. Microb. Ecol. Health Dis. 19, 7-16.
113. Rishi, P., Mavi, S. K., Bharrhan, S., Shukla, G., and Tewari, R. (2009). Protective efficacy of probiotic alone or in conjunction with a prebiotic in Salmonella-induced liver damage. FEMS Microbiol. Ecol. 69, 222-230.
114. Runyon, B. A., Squier, S., and Borzio, M. (1994). Translocation of gut bacteria in rats with cirrhosis to mesen-teric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J. Hepatol. 21, 792-796.
115. Sanchez, E., Casafont, F., Guerra, A., De Benito, I., and Pons-Romero, E. (2005). Role of intestinal bacterial overgrowth and intestinal motility in bacterial translocation in experimental cirrhosis. Rev. Esp. Enferm. Dig. 97, 805-814.
116. Satoh, M., Ando, S., Shinoda, T., and Yamazaki, M. (2008). Clearance of bacterial lipopolysaccharides and lipid A by the liver and the role of argininosuccinate synthase. Innate Immun. 14, 51-60.
117. Savage, D. C. (1977). Microbial ecology of the gastrointestinal tract. Annu. Rev. Microbiol. 31, 107-133.
118. Schafer, C., Parlesak, A., Schutt, C., Bode, J. C., and Bode, C. (2002). Concentrations of lipopolysaccha-ride-binding protein, bactericidal/ permeability-increasing protein, soluble CD 14 and plasma lipids in relation to endotoxaemia in patients with alcoholic liver disease. Alcohol Alcohol. 37, 81-86.
119. Schwabe, R. F., Bataller, R., and Brenner, D. A. (2003). Human hepatic stellate cells express CCR5 and RANTES to induce proliferation and migration. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G949-G958.
120. Schwandner, R., Dziarski, R., Wesche, H., Rothe, M., and Kirschning, C. J. (1999). Peptidoglycan-and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J. Biol. Chem. 274, 17406-17409.
121. Seki, E., De Minicis, S., Osterreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., et al. (2007). TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat. Med. 13, 1324-1332.
122. Seki, E., and Schnabl, B. (2012). Role of innate immunity and the micro-biota in liver fibrosis: crosstalk between the liver and gut. J. Physiol. 590, 447-458.
123. Shindo, K., Machida, M., Miyakawa, K., and Fukumura, M. (1993). A syndrome of cirrhosis, achlorhy-dria, small intestinal bacterial overgrowth, and fat malabsorption. Am. J. Gastroenterol. 88, 2084-2091.
124. Shukla, S., Shukla, A., Mehboob, S., and Guha, S. (2011). Meta-analysis: the effects of gut flora modulation using prebiotics, probiotics and synbiotics on minimal hepatic encephalopa-thy. Aliment. Pharmacol. Ther. 33, 662-671.
125. Simren, M., and Stotzer, P. O. (2006). Use and abuse of hydrogen breath tests. Gut 55, 297-303.
126. Sorensen, T. I., Orholm, M., Bentsen, K. D., Hoybye, G., Eghoje, K., and Christoffersen, P. (1984). Prospective evaluation of alcohol abuse and alcoholic liver injury in men as predictors of development of cirrhosis. Lancet 2, 241-244.
127. Stadlbauer, V., Mookerjee, R. P., Hodges, S., Wright, G. A., Davies, N. A., and Jalan, R. (2008). Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis. J. Hepatol. 48, 945-951.
128. Such, J., Guardiola, J. V., De Juan, J., Casellas, J. A., Pascual, S., Aparicio, J. R., et al. (2002). Ultrastructural characteristics of distal duodenum mucosa in patients with cirrhosis. Eur. J. Gastroenterol. Hepatol. 14, 371-376.
129. Tabata, T., Tani, T., Endo, Y., and Hanasawa, K. (2002). Bacterial translocation and peptidoglycan translocation by acute ethanol administration. J. Gastroenterol. 37, 726-731.
130. Tamai, H., Kato, S., Horie, Y., Ohki, E., Yokoyama, H., and Ishii, H. (2000). Effect of acute ethanol administration on the intestinal absorption of endotoxin in rats. Alcohol Clin. Exp. Res. 24, 390-394.
131. Teli, M. R., Day, C. P., Burt, A. D., Bennett, M. K., and James, O. F. (1995). Determinants of progression to cirrhosis or fibrosis in pure alcoholic fatty liver. Lancet 346, 987-990.
132. Terg, R., Fassio, E., Guevara, M., Cartier, M., Longo, C., Lucero, R., et al. (2008). Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study.J. Hepatol. 48, 774-779.
133. Tilg, H., and Day, C. P. (2007). Management strategies in alcoholic liver disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 4, 24-34.
134. Turnbaugh, P. J., Hamady, M., Yatsunenko, T., Cantarel, B. L., Duncan, A., Ley, R. E., et al. (2009). A core gut microbiome in obese and lean twins. Nature 457, 480-484.
135. Uesugi, T., Froh, M., Arteel, G. E., Bradford, B. U., and Thurman, R. G. (2001). Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 34, 101-108.
136. Vajro, P., Mandato, C., Licenziati, M. R., Franzese, A., Vitale, D. F., Lenta, S., et al. (2011). Effects of Lactobacillus rhamnosus strain GG in pediatric obesity-related liver disease. J. Pediatr. Gastroenterol. Nutr. 52, 740-743.
137. Wang, F., Graham, W. V., Wang, Y., Witkowski, E. D., Schwarz, B. T., and Turner, J. R. (2005). Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am. J. Pathol. 166, 409-419.
138. Wang, Y., Kirpich, I., Liu, Y., Ma, Z., Barve, S., McClain, C. J., et al. (2011). Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury. Am. I Pathol. 179, 2866-2875.
139. Wigg, A. J., Roberts-Thomson, I. C., Dymock, R. B., McCarthy, P. J., Grose, R. H., and Cummins, A. G. (2001). The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 48, 206-211.
140. Wu, Z. W., Lu, H. F., Wu, J., Zuo, J., Chen, P., Sheng, J. F., et al. (2011). Assessment of the fecal lactobacilli population in patients with hepatitis B virus-related decompensated cirrhosis and hepatitis B cirrhosis treated with liver transplant. Microb. Ecol. 63, 929-937.
141. Yan, A. W., Fouts, D. E., Brandl, J., Starkel, P., Torralba, M., Schott, E., et al. (2011). Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 53, 96-105.
142. Ye, D., Li, E Y., Lam, K. S., Li, H., Jia, W., Wang, Y., et al. (2012). Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice. Gut. 61, 1058-1067.
143. Yin, M., Bradford, B. U., Wheeler, M. D., Uesugi, T., Froh, M., Goyert, S. M., et al. (2001). Reduced early alcohol-induced liver injury in CD14-deficient mice. J. Immunol. 166, 4737-4742.
144. Yoon, Y H., and Yi, H. Y. (2010). Surveillance Report #88, Liver Cirrhosis Mortality in the United States, 1970-2007. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism.
145. Yoshimura, A., Lien, E., Ingalls, R. R., Tuomanen, E., Dziarski, R., and Golenbock, D. (1999). Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 163, 1-5.